VesSenDrugDeliv | A versatile platform for the design of targeting drug delivery vesicles

Summary
In the project of Marie Sklodowska-Curie Fellowship, I will design a versatile molecular platform that is used to construct multifunctional amphiphiles, which co-assemble with amphiphilic gold nanoparticles (AuNPs) to form monodisperse and stable targeting drug delivery vesicles. By incorporating multiple targeting ligands and multiple hydrophilic and hydrophobic drugs, I aim to discover efficient vesicle formulation with increased targeting selectivity and potent cytotoxicity to tumor cells. The route of the targeted drug delivery will be followed spontaneously via transiting surface plasmon resonance of AuNPs, and the impact of the targeted drug delivery on the targeted tumor cells will be monitored in real time by live cell Raman micro-spectroscopy. Furthermore, any targeting ligand, hydrophilic and hydrophobic drug can be easily tuned for a variety of different targeted tumour cells.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/659130
Start date: 01-07-2015
End date: 30-06-2017
Total budget - Public funding: 195 454,80 Euro - 195 454,00 Euro
Cordis data

Original description

In the project of Marie Sklodowska-Curie Fellowship, I will design a versatile molecular platform that is used to construct multifunctional amphiphiles, which co-assemble with amphiphilic gold nanoparticles (AuNPs) to form monodisperse and stable targeting drug delivery vesicles. By incorporating multiple targeting ligands and multiple hydrophilic and hydrophobic drugs, I aim to discover efficient vesicle formulation with increased targeting selectivity and potent cytotoxicity to tumor cells. The route of the targeted drug delivery will be followed spontaneously via transiting surface plasmon resonance of AuNPs, and the impact of the targeted drug delivery on the targeted tumor cells will be monitored in real time by live cell Raman micro-spectroscopy. Furthermore, any targeting ligand, hydrophilic and hydrophobic drug can be easily tuned for a variety of different targeted tumour cells.

Status

CLOSED

Call topic

MSCA-IF-2014-EF

Update Date

28-04-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.1. EXCELLENT SCIENCE
H2020-EU.1.3. EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions (MSCA)
H2020-EU.1.3.2. Nurturing excellence by means of cross-border and cross-sector mobility
H2020-MSCA-IF-2014
MSCA-IF-2014-EF Marie Skłodowska-Curie Individual Fellowships (IF-EF)